As of May 24
| +0.0895 / +22.40%|
The 2 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +820.25% increase from the last price of 0.49.
The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.